BridgeBio company sells off rare disease candidate to Galderma partner
28 Jan 2023 //
ENDPTS
PellePharm to Highlight Clinical Programs at the 29th Congress
29 Oct 2020 //
PRESSRELEASE
PellePharm Initiates Phase 2 Clinical Trial of Patidegib Topical Gel
08 Jan 2020 //
BUSINESS WIRE
PellePharm Initiates Phase 2 Clinical Trial of Patidegib Topical Gel
08 Jan 2020 //
BUSINESS WIRE
PellePharm Initiates Phase 2 Clinical Trial of Patidegib Topical Gel
07 Jan 2020 //
BUSINESS WIRE
PellePharm Completes of Pivotal Ph3 Clinical Trial of Patidegib Topical Gel
02 Dec 2019 //
BUSINESS WIRE
GE Healthcare executive jumps ship to lead dermatology biotech LEO
03 Jun 2019 //
FIERCE BIOTECH
PellePharm Initiates Pivotal Ph3 Clinical Trial of Patidegib Topical Gel
01 Apr 2019 //
BUSINESSWIRE
Local company EcoPharm harvesting plant used in hopeful cancer treatment
30 Mar 2019 //
UINTACOUNTRYHERALD
PellePharm Presents Updated Data from 2 PhII Studies of Patidegib Topical Gel
15 Oct 2018 //
BIOSPACE
Ravindran S to lead PellePharm as CEO; Moderna taps John Mendlein as president
05 Jan 2018 //
END POINTS
PellePharm readies hedgehog inhibitor for phase 3, plans series C after claiming
31 Jul 2017 //
FIERCE BIOTECH